S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Lithium Could Be 2023's Next Big Surprise (Ad)
3 Companies That Just Started Paying Dividends
The Squeeze Is On For EVGo, Rally To Follow 
Lithium Could Be 2023's Next Big Surprise (Ad)
Closing prices for crude oil, gold and other commodities
Used car prices are surging. Here's why you should buy now
Lithium Could Be 2023's Next Big Surprise (Ad)
Is The Bottom In For RH, Or Is This Just A Stopping Point? 
CNN preaches patience as ratings tank during turnaround
S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Lithium Could Be 2023's Next Big Surprise (Ad)
3 Companies That Just Started Paying Dividends
The Squeeze Is On For EVGo, Rally To Follow 
Lithium Could Be 2023's Next Big Surprise (Ad)
Closing prices for crude oil, gold and other commodities
Used car prices are surging. Here's why you should buy now
Lithium Could Be 2023's Next Big Surprise (Ad)
Is The Bottom In For RH, Or Is This Just A Stopping Point? 
CNN preaches patience as ratings tank during turnaround
S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Lithium Could Be 2023's Next Big Surprise (Ad)
3 Companies That Just Started Paying Dividends
The Squeeze Is On For EVGo, Rally To Follow 
Lithium Could Be 2023's Next Big Surprise (Ad)
Closing prices for crude oil, gold and other commodities
Used car prices are surging. Here's why you should buy now
Lithium Could Be 2023's Next Big Surprise (Ad)
Is The Bottom In For RH, Or Is This Just A Stopping Point? 
CNN preaches patience as ratings tank during turnaround
S&P 500   4,050.83
DOW   32,859.03
QQQ   315.68
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Lithium Could Be 2023's Next Big Surprise (Ad)
3 Companies That Just Started Paying Dividends
The Squeeze Is On For EVGo, Rally To Follow 
Lithium Could Be 2023's Next Big Surprise (Ad)
Closing prices for crude oil, gold and other commodities
Used car prices are surging. Here's why you should buy now
Lithium Could Be 2023's Next Big Surprise (Ad)
Is The Bottom In For RH, Or Is This Just A Stopping Point? 
CNN preaches patience as ratings tank during turnaround
NASDAQ:ADAP

Adaptimmune Therapeutics - ADAP Institutional Ownership

$1.06
0.00 (0.00%)
(As of 03/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.04
$1.10
50-Day Range
$1.06
$1.87
52-Week Range
$1.01
$2.65
Volume
250,503 shs
Average Volume
1.08 million shs
Market Capitalization
$163.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.12

Institutional Ownership Changes (13F Filings) for Adaptimmune Therapeutics (NASDAQ:ADAP)

Number of
Institutional Buyers
(last 12 months)
36
Total
Institutional Inflows
(last 12 months)
$20.04 M
Number of
Institutional Sellers
(last 12 months)
14
Total
Institutional Outflows
(last 12 months)
$6.07 M
Skip Chart & View Institutional Buying and Selling Data

ADAP Institutional Buying and Selling by Quarter

Get ADAP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Adaptimmune Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Lazard Asset Management LLC98,590$0.14M0.0%N/A0.060%
2/15/2023Virtu Financial LLC30,103$44K0.0%-25.7%0.018%
2/15/2023Millennium Management LLC164,659$0.24M0.0%+1,343.9%0.101%
2/15/2023Morgan Stanley2,289,848$3.34M0.0%+1.0%1.398%
2/15/2023Endurant Capital Management LP1,733,236$2.53M1.0%-3.1%1.058%
2/14/2023Susquehanna International Group LLP28,126$41K0.0%N/A0.017%
2/14/2023Marshall Wace LLP89,171$0.13M0.0%N/A0.054%
2/14/2023Two Sigma Investments LP22,600$33K0.0%N/A0.014%
2/14/2023Arrowstreet Capital Limited Partnership32,586$48K0.0%N/A0.020%
2/13/2023Geode Capital Management LLC105,910$0.15M0.0%+45.5%0.065%
2/13/2023GSA Capital Partners LLP141,084$0.21M0.0%-63.0%0.086%
2/10/2023Bank of America Corp DE4,738,612$6.92M0.0%+357.8%2.892%
2/10/2023Sei Investments Co.86,725$0.13M0.0%+177.2%0.053%
2/9/2023HBK Sorce Advisory LLC70,000$65K0.0%+100.0%0.043%
2/8/2023UBS Group AG23,625$34K0.0%+1,090.8%0.014%
1/24/2023Baillie Gifford & Co.17,169,939$25.07M0.0%+17.1%11.102%
1/17/2023Key Client Fiduciary Advisors LLC296,740$0.43M0.3%-31.9%0.181%
1/11/2023Vigilare Wealth Management28,800$42K0.0%-21.7%0.018%
11/15/2022State Street Corp309,298$0.33M0.0%-15.6%0.189%
11/15/2022PFM Health Sciences LP9,320,584$10.02M0.4%+2.3%5.689%
11/15/2022Long Focus Capital Management LLC4,789,490$5.15M0.5%+2.4%2.923%
11/15/2022Endurant Capital Management LP1,788,517$1.92M0.6%-1.9%1.092%
11/15/2022BlackRock Inc.1,414,247$1.52M0.0%+3.5%0.863%
11/14/2022Renaissance Technologies LLC566,232$0.61M0.0%+11.0%0.347%
11/14/2022HBK Sorce Advisory LLC35,000$32K0.0%N/A0.021%
11/10/2022ExodusPoint Capital Management LP370,288$0.40M0.0%+23.4%0.227%
11/7/2022Virtu Financial LLC40,503$44K0.0%+133.7%0.025%
11/3/2022Barclays PLC340,068$0.37M0.0%+34.6%0.208%
10/27/2022Baillie Gifford & Co.14,664,936$15.76M0.0%-4.3%8.977%
10/12/2022Key Client Fiduciary Advisors LLC435,985$0.47M0.4%+4.8%0.267%
8/22/2022ExodusPoint Capital Management LP300,000$0.51M0.0%N/A0.184%
8/16/2022Jane Street Group LLC44,086$75K0.0%N/A0.027%
8/15/2022State Street Corp366,525$0.62M0.0%-42.8%0.226%
8/15/2022Point72 Asset Management L.P.647,008$1.10M0.0%+11.1%0.399%
8/15/2022Millennium Management LLC122,122$0.21M0.0%-91.6%0.075%
8/13/2022Virtu Financial LLC17,328$29K0.0%-29.2%0.011%
8/13/2022Renaissance Technologies LLC510,000$0.87M0.0%-46.9%0.315%
8/12/2022Rafferty Asset Management LLC217,123$0.37M0.0%-59.5%0.134%
8/11/2022Alps Advisors Inc.96,110$0.16M0.0%N/A0.059%
8/11/2022JPMorgan Chase & Co.1,474,163$2.51M0.0%+5.3%0.910%
8/10/2022Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018%
8/8/2022Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457%
7/11/2022Vigilare Wealth Management41,800$71K0.1%N/A0.026%
6/7/2022Bank of America Corp DE524,212$1.08M0.0%-2.6%0.324%
5/17/2022Virtu Financial LLC24,470$50K0.0%N/A0.015%
5/17/2022Rock Springs Capital Management LP2,297,194$4.73M0.1%+3.7%1.419%
5/17/2022Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335%
5/16/2022Goldman Sachs Group Inc.359,919$0.74M0.0%+16.7%0.229%
5/16/2022State Street Corp640,620$1.32M0.0%+4.2%0.408%
5/16/2022Eversept Partners LP237,086$0.49M0.0%-32.0%0.151%
5/13/2022Renaissance Technologies LLC959,703$1.98M0.0%+124.4%0.612%
5/12/2022BlackRock Inc.1,330,839$2.74M0.0%+13.7%0.848%
5/12/2022Acadian Asset Management LLC44,208$91K0.0%N/A0.028%
5/12/2022Citigroup Inc.21,537$44K0.0%-28.3%0.014%
5/11/2022JPMorgan Chase & Co.1,399,765$2.88M0.0%-5.3%0.892%
5/11/2022GSA Capital Partners LLP69,612$0.14M0.0%-17.3%0.044%
5/5/2022Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805%
5/5/2022Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011%
4/29/2022Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023%
4/26/2022Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013%
4/21/2022Inspire Investing LLC31,928$66K0.0%+107.4%0.020%
4/21/2022Inspire Advisors LLC45,105$93K0.0%+193.0%0.029%
4/18/2022Key Client Fiduciary Advisors LLC420,447$0.87M0.7%+58.0%0.268%
2/14/2022Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384%
2/14/2022Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362%
2/14/2022DAFNA Capital Management LLC136,266$0.51M0.1%N/A0.087%
2/14/2022Eversept Partners LP348,716$1.31M0.1%-21.6%0.223%
2/14/2022GSA Capital Partners LLP84,129$0.32M0.0%-82.6%0.054%
2/11/2022Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882%
2/10/2022Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388%
2/8/2022Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344%
2/8/2022ProShare Advisors LLC19,315$72K0.0%-34.0%0.012%
2/7/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$0.28M0.0%+13.6%0.044%
2/3/2022Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016%
2/3/2022Inspire Investing LLC15,393$58K0.0%N/A0.010%
1/27/2022Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007%
1/20/2022Baillie Gifford & Co.13,756,352$51.59M0.0%+7.3%8.807%
12/1/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%
11/18/2021Personal CFO Solutions LLC36,388$0.19M0.0%+19.7%0.023%
11/16/2021Schonfeld Strategic Advisors LLC349,683$1.81M0.0%-1.7%0.224%
11/16/2021ACT Capital L.L.C.90,000$0.47M0.2%N/A0.058%
11/16/2021Squarepoint Ops LLC31,881$0.17M0.0%+127.8%0.020%
11/16/2021Toroso Investments LLC10,554$55K0.0%N/A0.007%
11/16/2021Millennium Management LLC1,584,849$8.19M0.0%+70.3%1.015%
11/15/2021Point72 Asset Management L.P.76,300$0.39M0.0%-96.3%0.049%
11/15/2021Cubist Systematic Strategies LLC57,953$0.30M0.0%+485.4%0.037%
11/15/2021Man Group plc148,305$0.77M0.0%+44.2%0.095%
11/15/2021Tudor Investment Corp Et Al16,004$83K0.0%N/A0.010%
11/15/2021Rock Springs Capital Management LP2,189,788$11.32M0.2%+41.7%1.403%
11/15/2021Marshall Wace LLP1,553,800$8.03M0.0%N/A0.995%
11/15/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%
11/15/2021Wealthspire Advisors LLC11,750$61K0.0%N/A0.008%
11/15/2021Virtus ETF Advisers LLC47,350$0.25M0.1%-5.0%0.030%
11/15/2021Eversept Partners LP444,887$2.30M0.2%N/A0.285%
11/15/2021GSA Capital Partners LLP484,782$2.51M0.3%-5.6%0.311%
11/12/2021Trexquant Investment LP23,609$0.12M0.0%N/A0.015%
11/12/2021Blueshift Asset Management LLC11,933$62K0.0%N/A0.008%
11/10/2021US Bancorp DE5,729$29K0.0%+403.0%0.004%
11/10/2021Goldman Sachs Group Inc.330,378$1.71M0.0%-13.3%0.212%
11/10/2021KBC Group NV45,900$0.24M0.0%+77.2%0.029%
(Data available from 1/1/2016 forward)













ADAP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ADAP shares?

During the previous two years, 77 institutional investors and hedge funds held shares of Adaptimmune Therapeutics. The most heavily invested institutionals were Baillie Gifford & Co. ($25.07M), PFM Health Sciences LP ($10.02M), Avoro Capital Advisors LLC ($8.62M), Bank of America Corp DE ($6.92M), Syncona Portfolio Ltd ($5.17M), Long Focus Capital Management LLC ($5.15M), and Rock Springs Capital Management LP ($4.73M).Learn more on ADAP's institutional investors.

Which institutional investors have been buying Adaptimmune Therapeutics stock?

Of the 73 institutional investors that purchased Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baillie Gifford & Co. ($7.53M), Bank of America Corp DE ($3.70M), Long Focus Capital Management LLC ($2.27M), Endurant Capital Management LP ($1.89M), Marshall Wace LLP ($1.64M), Syncona Portfolio Ltd ($1.38M), and PFM Health Sciences LP ($1.34M).

How much institutional buying is happening at Adaptimmune Therapeutics?

Institutional investors have bought a total of 31,907,029 shares in the last 24 months. This purchase volume represents approximately $112.02M in transactions.

Which Adaptimmune Therapeutics major shareholders have been selling company stock?

Of the 31 institutional investors that sold Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Morgan Stanley ($3.10M), Millennium Management LLC ($2.12M), Point72 Asset Management L.P. ($1.98M), Avoro Capital Advisors LLC ($1.53M), Renaissance Technologies LLC ($1.24M), Healthcare of Ontario Pension Plan Trust Fund ($0.97M), and GSA Capital Partners LLP ($0.91M).

How much institutional selling is happening at Adaptimmune Therapeutics?

Institutional investors have sold a total of 15,887,503 shares in the last 24 months. This volume of shares sold represents approximately $62.14M in transactions.

This page (NASDAQ:ADAP) was last updated on 3/31/2023 by MarketBeat.com Staff